Cargando…
Association Between Cannabinoid Receptor-1 Gene Polymorphism and the Risk of Diabetic Nephropathy Among Patients with Type 2 Diabetes Mellitus
BACKGROUND: The cannabinoid receptor 1 (CNR1) gene polymorphism is reportedly associated with components of metabolic syndrome and coronary artery diseases in patients with type 2 diabetes mellitus (T2DM). We investigated whether the common variant rs10493353 polymorphism is associated with diabetic...
Autores principales: | Zhang, Xuelian, Zhu, Haiqing, Xing, Xiaoyan, Zhang, Chunyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669503/ https://www.ncbi.nlm.nih.gov/pubmed/33209051 http://dx.doi.org/10.2147/PGPM.S278897 |
Ejemplares similares
-
Association Between Lipoprotein (A) and Diabetic Nephropathy in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis
por: Ren, Xiaoyan, et al.
Publicado: (2021) -
Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy
por: Barutta, Federica, et al.
Publicado: (2011) -
Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy
por: Barutta, Federica, et al.
Publicado: (2010) -
AT2R -1332 G:A polymorphism and diabetic nephropathy in type 2 diabetes mellitus patients
por: Rahimi, Zohreh, et al.
Publicado: (2013) -
Polymorphism of Angiotensin-Converting Enzyme (rs4340) and Diabetic Nephropathy in Caucasians with Type 2 Diabetes Mellitus
por: Šeruga, M, et al.
Publicado: (2016)